Health - Google News: US FDA panel backs Sanofi, Isis drug for rare disorder - Reuters

Health - Google News Google News

US FDA panel backs Sanofi, Isis drug for rare disorder - Reuters Oct 18th 2012, 20:33 The West Australian US FDA panel backs Sanofi, Isis drug for rare disorder Reuters WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts recommended the Sanofi SA and Isis Pharmaceutical Inc drug, Kynamro, for treatment of a rare genetic disorder that causes unusually high cholesterol and ... FDA Panel Recommends Approval Of Mipomersen For Familial ...Forbes Genzyme's mipomersen wins key FDA panel vote for rare cases of HoFHFierceBiotech FDA advisors vote 9 to 6 to approve mipomersen for homozygous FHTheHeart.Org Fox Business -Family Practice News Digital Network -Mass High Tech all 16 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: